Authors : Harshil R.Thakkar; Mohammadarsh B. Mansuri; Dr. Khushbu Patel; Dr. C. N. Patel

Volume/Issue : Volume 10 - 2025, Issue 1 - January

Google Scholar : https://tinyurl.com/2z486w25

Scribd : https://tinyurl.com/3wtuy9c9

DOI : https://doi.org/10.5281/zenodo.14836665

Abstract : Dapagliflozin is an anti-diabetic drug. Dapagliflozin comes under new class of SGLT-2 inhibitor. It is administered as tablets. This therapeutic agent used for type 2 diabetes mellitus. Dapagliflozin functions by inhibiting glucose reabsorption in the proximal tubules of the kidney's nephron, it efficiently lowers blood glucose levels and promotes glycosuria. In this review article we study about profile of Dapagliflozin which include mechanism of action, pharmacokinetics, pharmacodynamics, adverse effects and drug interactions. Also reported analytical methods including UV, HPLC and HPTLC for assessment of Dapagliflozin single form and Dapagliflozin with other drugs are reviewed in this article.

Keywords : Diabetes Mellitus, Anti-diabetic, Dapagliflozin, SGLT-2 Inhibitor, UV, HPLC, HPTLC.

References :

1. Ved Prakash Singh. An Overview on Anti Diabetic Drugs and Development. Sci. Tech. J., 2016, 4(2), 2321-3388.
2. M. Abinaya, R. Kalki, E. Sibichanduru, A. Sivabalan, Sankar Saravanan and S. A. Vadivel. A Comprehensive Review Of Phytomolecules Used In Anti-diabetic Activities. Euro. J. Biomed. Pharm. Sci., 2024, 11(6), 77-90.
3. Jayanta Dowarah, Ved Prakash Singh. Anti-diabetic drugs recent approaches and advancements. Bioorg. Med. Chem., 2020, 28(5), 115263.
4. Wikipedia, "Diabetes Medication", December 2024, https://en.m.wikipedia.org/wiki/Diabetes_medication
5. Mujahid A Saeed, Parth Narendran. Dapagliflozin for the treatment of type 2 diabetes: a review of the literature. Drug Des. Devel. Ther., 2014, 8, 2493–2505.
6. Naazneen Maksud, Sidhant Bera, Mohd Javed Naim, Ozair Alam. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus. Euro. J. Med. Chem., 2024, 11, 100167.
7. Inderbir S. Padda, Arun U. Mahtani, Mayur Parmar. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. Statpearls, 2024.
8. Drug bank (DB06292), “Dapagliflozin”, December 2024, https://go.drugbank.com/drugs/DB06292
9. Chemical book (CB91011730), “Dapagliflozin”, December 2024, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB91011730.htm
10. Guide to pharmacology, “Dapagliflozin”, December 2024, https://www.guidetopharmacology.org/GRAC/LigandDisplayForward ligandId=4594
11. Sohita Dhillon. Dapaglifozin: A Review in Type 2 Diabetes. Adis Drug Evaluation, 2019, 79, 1135–1146.
12. Martha K Nicholson, Randa Ghazal Asswad, John PH Wildin. Dapagliflozin for the treatment of type-2 diabetes mellitus – an update. Expert Opinion On Pharmacotherapy, 2021, 22(17), 2303–2310.
13. MedlinePlus, "Dapagliflozin", December 2024, https://medlineplus.gov/druginfo/meds/a614015.html
14. V.B.Tambe, P.S. Tajane, R. K. Godge. Analytical method Development and Validation of Dapagliflozin by UV-spectroscopy. Int. J. of Food and Nutri. Sci., 2022, 11(1), 709-716.
15. Karuna Priya Chitra, M. China Eswaraiah and M. V. Basaveswara Rao. Unique UV Spectrophotometric Method for Reckoning of Dapagliflozin in Bulk and Pharmaceutical Dosage Forms. J. Chem. Pharm. Res., 2015, 7(9), 45-49.
16. Gajanan Vithoba Mante, Krishna Radheshyam Gupta and Atul Tryambakrao Hemke. Estimation of Dapagliflozin From its Tablet Formulation by UV-Spectrophotometry. Pharm. Methods., 2017, 8(2), 102-107.
17. Shilpi Pathak. Development and Validation of UV-Spectroscopy Method for the Determination of Dapagliflozin. Bull. Env. Pharmacol. Life Sci., 2020, 9(12), 128-133.
18. M. Sanagapati, K. Dhanalakshmi, G. Nagarjuna Reddy, B. Kavitha. Method Development and Validation of Dapagliflozin API by UV-Spectroscopy. Int. J. Pharm. Sci. Revi. Res., 2014, 27(1), 270-272.
19. Shakir Basha s, Sravanthi p. Development and Validation of Dapagliflozin by RP- HPLC Method and it's Forced Degradation Studies. Asian. J. Pharm. Clin. Res., 2017, 10(11), 101-105.
20. G. V. Mante, A. T. Hemke and M. J. Umekar. RP-HPLC Method for Estimation of Dapagliflozin From its Tablet. Int. J. Chem. Tech. Res., 2018, 11(01), 242-248.
21. Mitali. V. Verma, Chirag. J. Patel, M. M. Patel. Development and Stability Indicating HPLC Method for Dapagliflozin in API and Pharmaceutical Dosage Form. Int. J. App. Pharm., 2017, 9(5), 33-41.
22. Asmita V. Gaikwad, Ashwini S. Gawade, Hupparage Vrushabh B., Shubhrajit Mantry, Aditya Kale, Jaydeep Kale. Method Development and Validation of Dapagliflozin by RP-HPLC. J. Pharm. Neg. Resul., 2022, 13(6), 4316-4335.
23. Jitendra Debata, Sundeep Kumar, Sajal Kumar Jha, Amjad Khan. A New RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Dosage Form. Int. J. Drug. Dev & Res., 2017, 9(2), 48-51.
24. Mayuri Bhokare, Dr. Pradyumna Ige. Analytical Method Development and Validation of Dapagliflozin by RP-HPLC Method in Tablet Dosage Form. Int. J. of Pharm. Sci., 2024, 2(7), 1718-1728.
25. Lohiya G. V., Mahima Jadhav, Rohini Ghotmukle, et al. RP-HPLC Method Development and Validation on Dapagliflozin. Int. J. of Pharm. Sci., 2024, 2(7), 1766- 1779.
26. Manasa Sanagapati, et al. Development and Validation of Stability-Indicating RP- HPLC Method for Determination of Dapagliflozin. J. Adv. Pharm. Edu. & Res., 2014, 4(3), 350-353.
27. B. V. Suma, Deveswaran. R, Premnath Shenoy. A New HPTLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Dosage Form. Int. J. Pharm. Pharm. Sci., 2019, 11(8), 58-63.
28. Snehal. R. Karmankar, Madhukar. R. Tajne. A Validated Stability Indicating HPTLC Method for the Analysis of Dapagliflozin in Bulk Drug and Marketed Tablet Formulation. Asian. J. Chem., 2019, 31(7), 1457-1460.
29. Sufiyan Ahmad, Md. Rageeb Usman, et al. Development and Validation Of UV- Spectrophotometric Method For Estimation Of Saxagliptin And Dapagliflozin In Bulk and Dosage Form. Int. J. Pharma. Sci. Res., 2021, 12(4), 2185-2192.
30. K. Bhavyasri, T. Surekha, M. Sumakanth. Method Development, Validation and Stress Studies of Dapagliflozin and Metformin Hydrochloride Using Ultraviolet-Visible Spectroscopy in Bulk and Combined Pharmaceutical Formulations. Biosc.Biotech.Res.Comm., 2020, 13(4), 1986-1992.
31. Jani BR, Shah KV, Kapupara PP. Development and Validation of UV Spectroscopic First Derivative Method for Simultaneous Estimation of Dapagliflozin and Metformin Hydrochloride in Synthetic Mixture. J Bioequiv., 2015, 1(1), 1-8.
32. Dhanya B Sen, Sohil Jatu1, Rajesh A Maheshwari, et al. New Eco-friendly UV- spectroscopic Methods for Simultaneous Assessment of Dapagliflozin, Saxagliptin and Metformin in Ternary Mixture. Ind. J. Pharm. Edu. Res., 2023, 57(2), 559-569.
33. Ashim Kumar Sen, Satish B. Khatariya, Dhanya B. Sen, et al. Various Innovative UV- spectroscopic Methodologies for Concurrent Estimation of Dapagliflozin and Vildagliptin in Combined Tablet. J. App. Pharma. Sci., 2023, 13(9), 213-223.
34. Raghvendra Singh Bhadauria, Vikas Agarwal. Development and Validation of UV- Spectroscopic Method for Simultaneous Estimation of Dapagliflozin and Saxagliptin in Marketed Formulation. J. Drug Deliv. Therapeu., 2019, 9(4-s), 1160-1164.
35. Suganthi A, Syed Iffran I, Ravi T. Development of a Validated Highly Sensitive and Eco Friendly Approach for the Simultaneous Determination of Dapagliflozin and Gliclazide in Bulk and Tablet Formulation by RP-HPLC Method. YMER., 2024, 23(5), 560-570.
36. Dhanshri S Nandre, Aejaz Ahmed, Khan GJ. Stability Indicating HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Metformin Tablet Dosage Form. Asian. J. Pharm. Clin. Res., 2022, 15(10), 109-114.
37. Krishna Rao Vankalapati, Pallavi Alegete, Sathyanarayana Boodida. Stability Indicating HPLC Method Development and Validation for Simultaneous Estimation of Metformin, Dapagliflozin and Saxagliptin in Bulk Drug and Pharmaceutical Dosage Form. Bio. Chrom., 2022, 36(7).
38. Khagga Bhavyasri, Thaneeru Surekha, et al. RP-HPLC Method for Dapagliflozin and Metformin HCL in Bulk and Combined Formulation. Arch. Pharm. Pract., 2022, 12(4), 106-10.
39. Sharmila Donepudi, Suneetha Achanta. Simultaneous Estimation of Saxagliptin and Dapagliflozin in Human Plasma by Validated High Performance Liquid Chromatography Ultraviolet Method. Turk. J. Pharm. Sci., 2019, 16(2), 227-233.
40. Thiyagarajan Deepan, Magharla Dasaratha Dhanaraju. Stability Indicating HPLC Method for the Simultaneous Determination of Dapagliflozin and Saxagliptin in Bulk and Tablet Dosage Form. Curr. Issues. Pharm. Med. Sci., 2018, 31(1), 39-43.
41. Afshan Urooj, P. Shyam Sundar, et al. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Metformin in Bulk and in Synthetic Mixture. World. J. Pharm. Pharm. Sci., 2017, 6(7), 2139-2150.
42. Afnan E. Abdelrahman, Hadir M. Maher, Nourah Z. Alzoman. HPTLC Method for the Determination of Metformin Hydrochloride, Saxagliptin Hydrochloride, and Dapagliflozin in Pharmaceuticals. Curr. Anal. Chem., 2020, 16(5), 609-619.
43. Parixit Prajapati, Pankaj Kapupara, Hitesh Vekariya. Development and Validation of HPTLC Method for Simultaneous Quantification of Dapagliflozin and Vildagliptin in Tablet Dosage Form. J. Chem. Health. Risks., 2023, 13(6), 3643-3649.
44. Anchal Shukla, Usmangani Chhalotiya, et al. Development and Validation of Stability Indicating HPTLC Method for Simultaneous Estimation of Dapaglifozin and Linagliptin. Disc. Chem., 2024, 1(4).
45. Saloni A Desai, Rajnikant B. Mardia, B. N. Suhagia, Hemang T. Desai. Development and Validation of Stability-Indicating HPTLC Method for Simultaneous Estimation of Metformin, Saxagliptin and Dapagliflozin in their Combined Matrix Using AQbD. Bull. Env. Pharmacol. Life Sci., 2022, 12(1), 32-42.
46. Arun Maruti Kashid, Aditya Mahesh Shinde, Vaibhav Balasaheb Pere, Shraddha Vikram Tathe. Stability-Indicating HPTLC Method Development and Validation for Dapagliflozin Propanediol Monohydrate, Vildagliptin, and Metformin Hydrochloride in Active Pharmaceutical Ingredient and its Tablet Dosage Form. J. Plan. Chrom. Mode. TLC., 2024, 37(1).